Urology Residency
College
- Center City Campus
- Sidney Kimmel Medical College
Degree Earned
- Residency
Program Length
5 years
Program Type
- On Campus
Call to Actions
Leadership
Position:
Program Director, Residency Program
Email:
[email protected]
Leadership
Position:
Associate Program Director
Email:
[email protected]
Leadership
Position:
Associate Program Director
Contact Us
Department:
Sidney Kimmel Medical College
1025 Walnut Street
College Building, Suite 1112
Philadelphia, PA 19107
Contact Number(s):
Jefferson Department of Urology Publications
- A student-community partnership to enhance cancer research training
- Metastatic prostate adenocarcinoma to the brain – a clinicopathologic analysis of 21 cases
- Succinate Dehydrogenase Deficient Renal Cell Carcinoma With Sarcomatoid and Rhabdoid Features—A Diagnostic Dilemma
- The impact of Marfan syndrome and Ehlers-Danlos syndrome on the risk of penile fracture in patients between 18 and 45 years
- Artificial intelligence improves urologic oncology patient education and counseling
- Clinical, Diagnostic, and Metabolic Characteristics Associated with Nephrolithiasis in the Black Women’s Health Study
- Changes in Facility Share of Medicaid-insured Patients With Urologic Cancers Following Implementation of the Patient Protection and Affordable Care Act
- Antibiotic dip and irrigation solutions confer increased antimicrobial efficacy of inflatable penile prosthesis hydrophilic surfaces compared with 0.05% chlorhexidine gluconate
- Minocycline-rifampin-impregnated penile prosthesis surfaces retain antimicrobial activity following irrigation with 0.05% chlorhexidine gluconate and antibiotic solutions
- Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer
- A global, propensity-score matched analysis of patients receiving inflatable penile prostheses and the risk of complications, infections, and re-interventions
- Appropriateness of Imaging for Low-Risk Prostate Cancer—Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC)
- PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer
- Editorial Commentary
- Efficacy of Intravesical Nadofaragene Firadenovec for Patients with Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up from a Phase 3 Trial
- Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
- Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
- Complete urethral disruption after motor vehicle crash without pelvic fracture
- Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
- Percutaneous Microwave Ablation versus Cryoablation for Small Renal Masses (≤4 cm): 12-Year Experience at a Single Center